NON-METASTATIC PROSTATE CANCER
Clinical trials for NON-METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for NON-METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug combo tested to fight aggressive prostate cancer
Disease control OngoingThis study is testing whether adding two oral drugs, darolutamide and abemaciclib, to standard hormone therapy is safe and effective for men with high-risk prostate cancer. The first part aims to find the best dose, and the second part would have compared the full combination to …
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Praful Ravi, MB BCHir, MRCP • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Prostate cancer drugs put to the test: which one protects your mind?
Symptom relief OngoingThis study aims to find out which of two common prostate cancer medications—enzalutamide or darolutamide—has less impact on memory, concentration, and other thinking skills. About 111 men with advanced prostate cancer will take one of the drugs and complete regular computer-based…
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC